abstract |
The present invention provides a therapeutic agent field. Specifically, the invention provides in vitro processed dendritic cells that are conditionally expressing interleukin-12 (IL-12) under the control of a gene expression regulatory system in the presence of an active ligand for therapeutic use in an animal, including a human, Provides a method of production. |